Journal
ACS CHEMICAL BIOLOGY
Volume 15, Issue 6, Pages 1541-1553Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.0c00160
Keywords
-
Categories
Funding
- Spanish Ministry of Economy and Competitiveness, MINECO [BIO2014-56752-R, PIM2010EEI-00752]
- grant Apoyo a grupos de excelencia, Principado de Asturias-FEDER [FC-15-GRUPIN14-014]
- MINECO
- Ministerio de Ciencia e Innovacion [PCT-010000-2010-4]
Ask authors/readers for more resources
Largimycins are hybrid nonribosomal peptide-polyketides that constitute a new group of metabolites in the leinamycin family of natural products displaying unique structural features such as containing an oxazole instead of a thiazole ring or being oxime ester macrocycles, unprecedented in nature, rather than macrolactams. Their discovery in Streptomyces argillaceus and Streptomyces canus has relied on the activation of two homologous silent gene clusters by overexpressing a transcriptional activator and cultivating in specific media. The proposed biosynthesis of largimycins includes the key action of the oxidoreductase LrgO, responsible for the formation of the oxime group involved in macrocyclization, and two putative cryptic biosynthetic steps consisting of chlorination of L-Thr by the NRPS loading module and incorporation of an olefinic exomethylene group by LrgJ PKS. The discovery of largimycins uncovers novel biosynthetic avenues employed in nature to enrich the structural diversity of leinamycins and provides tools for combinatorial biosynthesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available